Qiagen NV reported $301.89M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Akebia Therapeutics USD 13M 2.61M Mar/2026
argenx SE USD 473.53M 132.91M Dec/2025
Avita Medical AUD 6.93M 614K Dec/2025
Ionis Pharmaceuticals USD 5.56M 4.49M Mar/2026
Moderna USD 146M 7M Mar/2026
Organon & Co USD 1.37B 33M Mar/2026
Qiagen NV USD 301.89M 11.66M Dec/2025
Revvity USD 387.5M 8.01M Mar/2026
Viatris USD 3.93B 72.2M Mar/2026
Xeris Pharmaceuticals USD 74.23M 5.56M Mar/2026